Around the world, 650 million people are living with
obesity.1 By the year 2030, it’s expected that 250 million
children will be living with it.2 Novo Nordisk is committed
to tackling obesity and the complications associated with it.
A global leader in diabetes care for nearly 100 years, our focus is
on the serious chronic diseases that affect hundreds of millions of
people and are among the most urgent global health challenges. Our
goal: to pioneer scientific breakthroughs, expand access to our
medicines and prevent and ultimately cure the diseases we treat.
With its increasing global prevalence, obesity has rightly come into
focus for Novo Nordisk, and we’ve already accomplished a lot as part
of our long-term commitment to Changing
Obesity™. Join us as we continue to drive positive change for
millions across the globe living with obesity. Be a part of our
mission to change the way the world sees, prevents and treats obesity.
We have exciting opportunities spread across the business and across
Let’s solve the global pandemic and change lives. Together.
Together we’re life-changing.
Read more, apply – or share!